The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal HemoglobinuriaPeter Hillmen, Lucio Luzzatto, Neal S. Young et al.|New England Journal of Medicine|2006Cited by 1.3k
Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuriaPeter Hillmen, Neal S. Young, Petra Muus et al.|Blood|2007Cited by 578
High-Dose Cytarabine in Induction Treatment Improves the Outcome of Adult Patients Younger Than Age 46 Years With Acute Myeloid Leukemia: Results of the EORTC-GIMEMA AML-12 TrialR. Willemze, Théo de Witte, Sergio Amadori et al.|Journal of Clinical Oncology|2013Cited by 168
Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemiaBruno Fattizzo, Austin Kulasekararaj, Robin Ireland et al.|Leukemia|2021Cited by 74